G1J Ile-de-France is a closed private equity fund managed by Cap Decisif.
InnaVirVax, a French biopharmaceutical firm focused on treating infectious and chronic diseases, has closed its third funding round at $4m.
Read more news concerning G1J Ile-de-France
Cap Decisif is a private equity general partner firm headquartered in Paris, France.
View full profile
Registration is fast, free and easy
Already a member?